As of 2026-05-26, the EV/EBITDA ratio of Hester Biosciences Ltd (HESTERBIO.NS) is 23.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HESTERBIO.NS's latest enterprise value is 18,180.66 mil INR. HESTERBIO.NS's TTM EBITDA according to its financial statements is 771.28 mil INR. Dividing these 2 quantities gives us the above HESTERBIO.NS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 21.7x - 22.2x | 21.9x |
| Forward P/E multiples | 10.7x - 16.1x | 13.1x |
| Fair Price | 1,121.56 - 1,804.46 | 1,585.25 |
| Upside | -40.8% - -4.8% | -16.3% |
| Date | EV/EBITDA |
| 2026-05-25 | 23.57 |
| 2026-05-22 | 23.55 |
| 2026-05-21 | 23.47 |
| 2026-05-20 | 22.97 |
| 2026-05-19 | 22.69 |
| 2026-05-18 | 22.27 |
| 2026-05-15 | 22.79 |
| 2026-05-14 | 21.96 |
| 2026-05-13 | 21.31 |
| 2026-05-12 | 21.31 |
| 2026-05-11 | 21.85 |
| 2026-05-08 | 20.60 |
| 2026-05-07 | 20.76 |
| 2026-05-06 | 21.04 |
| 2026-05-05 | 20.60 |
| 2026-05-04 | 20.78 |
| 2026-04-30 | 20.60 |
| 2026-04-29 | 21.33 |
| 2026-04-28 | 21.26 |
| 2026-04-27 | 21.00 |
| 2026-04-24 | 19.17 |
| 2026-04-23 | 18.91 |
| 2026-04-22 | 19.14 |
| 2026-04-21 | 18.92 |
| 2026-04-20 | 18.91 |
| 2026-04-17 | 19.07 |
| 2026-04-16 | 19.11 |
| 2026-04-15 | 18.72 |
| 2026-04-13 | 18.53 |
| 2026-04-10 | 18.78 |
| 2026-04-09 | 18.43 |
| 2026-04-08 | 18.28 |
| 2026-04-07 | 18.43 |
| 2026-04-06 | 18.38 |
| 2026-04-02 | 18.17 |
| 2026-04-01 | 17.74 |
| 2026-03-30 | 16.57 |
| 2026-03-27 | 17.13 |
| 2026-03-25 | 17.67 |
| 2026-03-24 | 17.75 |
| 2026-03-23 | 17.44 |
| 2026-03-20 | 17.96 |
| 2026-03-19 | 18.44 |
| 2026-03-18 | 18.37 |
| 2026-03-17 | 18.25 |
| 2026-03-16 | 18.80 |
| 2026-03-13 | 17.88 |
| 2026-03-12 | 18.44 |
| 2026-03-11 | 18.56 |
| 2026-03-10 | 18.95 |